Paul J Durand

Array ( [id] => 9323170 [patent_doc_number] => 08658188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-25 [patent_title] => 'Radio-opaque bioactive glass materials' [patent_app_type] => utility [patent_app_number] => 13/390945 [patent_app_country] => US [patent_app_date] => 2010-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7967 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954515 [patent_doc_number] => 20110034548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'Method for Suspending a Flavonoid in a Beverage' [patent_app_type] => utility [patent_app_number] => 12/853384 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034548.pdf [firstpage_image] =>[orig_patent_app_number] => 12853384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6197310 [patent_doc_number] => 20110029068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'DRUG DELIVERY SYSTEM AND METHOD OF MANUFACTURING THEREOF' [patent_app_type] => utility [patent_app_number] => 12/851161 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6414 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20110029068.pdf [firstpage_image] =>[orig_patent_app_number] => 12851161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7769188 [patent_doc_number] => 20120035741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'SELF-EXPANDABLE BIOPOLYMER-MINERAL COMPOSITE' [patent_app_type] => utility [patent_app_number] => 12/850758 [patent_app_country] => US [patent_app_date] => 2010-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3515 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035741.pdf [firstpage_image] =>[orig_patent_app_number] => 12850758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311306 [patent_doc_number] => 08652522 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'Pharmaceutical composition of an iontophoresis' [patent_app_type] => utility [patent_app_number] => 13/388295 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 12876 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9020513 [patent_doc_number] => 08530500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Stable pharmaceutical omeprazole formulation for oral administration' [patent_app_type] => utility [patent_app_number] => 12/839495 [patent_app_country] => US [patent_app_date] => 2010-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5149 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12839495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6102588 [patent_doc_number] => 20110166081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Alpha-dystroglycan as a Protein Therapeutic' [patent_app_type] => utility [patent_app_number] => 12/836874 [patent_app_country] => US [patent_app_date] => 2010-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14009 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166081.pdf [firstpage_image] =>[orig_patent_app_number] => 12836874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8209132 [patent_doc_number] => 20120128789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'USE OF XENON FOR TREATING HYPERSENSITIVITY TO PAIN' [patent_app_type] => utility [patent_app_number] => 13/387285 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1756 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20120128789.pdf [firstpage_image] =>[orig_patent_app_number] => 13387285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8184423 [patent_doc_number] => 20120114768 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'ANGIOGENESIS REGULATING COMPOSITION AND METHOD FOR REGULATING ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 13/383805 [patent_app_country] => US [patent_app_date] => 2010-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6736 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20120114768.pdf [firstpage_image] =>[orig_patent_app_number] => 13383805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9112577 [patent_doc_number] => 08568745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-29 [patent_title] => 'Water-soluble drug carrier and process for producing the same' [patent_app_type] => utility [patent_app_number] => 13/382705 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 23 [patent_no_of_words] => 10215 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8305441 [patent_doc_number] => 08226971 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-24 [patent_title] => 'Catheter lock solution comprising citrate and a paraben' [patent_app_type] => utility [patent_app_number] => 12/792286 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11465 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12792286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6575188 [patent_doc_number] => 20100234900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-16 [patent_title] => 'ENDOSSEOUS IMPLANT' [patent_app_type] => utility [patent_app_number] => 12/788815 [patent_app_country] => US [patent_app_date] => 2010-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4235 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20100234900.pdf [firstpage_image] =>[orig_patent_app_number] => 12788815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6380974 [patent_doc_number] => 20100316725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 12/788196 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17787 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0316/20100316725.pdf [firstpage_image] =>[orig_patent_app_number] => 12788196 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033049 [patent_doc_number] => 20110082074 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'AGENT FOR PREVENTING PERIODONTAL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/785942 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9324 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082074.pdf [firstpage_image] =>[orig_patent_app_number] => 12785942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6410866 [patent_doc_number] => 20100275943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'FORMULATIONS FOR MAINTAINING THE FORM OF A SPECIFIC HAIRCUT' [patent_app_type] => utility [patent_app_number] => 12/773694 [patent_app_country] => US [patent_app_date] => 2010-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5683 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20100275943.pdf [firstpage_image] =>[orig_patent_app_number] => 12773694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545589 [patent_doc_number] => 20100204800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'MULTI-POLYMER HYDROGELS' [patent_app_type] => utility [patent_app_number] => 12/767016 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4924 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204800.pdf [firstpage_image] =>[orig_patent_app_number] => 12767016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8606164 [patent_doc_number] => 20130011477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Stable Pharmaceutical Composition of Imatinib' [patent_app_type] => utility [patent_app_number] => 13/637165 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1795 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637165 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7807244 [patent_doc_number] => 20120058198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-08 [patent_title] => 'METHODS FOR TREATING AND PREVENTING PNEUMONIA AND VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS' [patent_app_type] => utility [patent_app_number] => 13/259615 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22862 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20120058198.pdf [firstpage_image] =>[orig_patent_app_number] => 13259615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635603 [patent_doc_number] => 20100226897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHOD FOR MODIFYING THE WETTABILITY AND/OR OTHER BIOCOMPATIBILITY CHARACTERISTICS OF A SURFACE OF A BIOLOGICAL MATERIAL BY THE APPLICATION OF GAS CLUSTER ION BEAM TECHNOLOGY AND BIOLOGICAL MATERIALS MADE THEREBY' [patent_app_type] => utility [patent_app_number] => 12/722126 [patent_app_country] => US [patent_app_date] => 2010-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7721 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226897.pdf [firstpage_image] =>[orig_patent_app_number] => 12722126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6236302 [patent_doc_number] => 20100267642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'USE OF COMPLEX FORMS OF CALMODULIN-LIKE SKIN PROTEIN CLSP' [patent_app_type] => utility [patent_app_number] => 12/686672 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8394 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267642.pdf [firstpage_image] =>[orig_patent_app_number] => 12686672 [rel_patent_id] =>[rel_patent_doc_number] =>)